E

Eton Pharmaceuticals
D

ETON

19.920
USD
-0.33
(-1.63%)
مغلق
حجم التداول
11,852
الربح لكل سهم
0
العائد الربحي
-
P/E
-111
حجم السوق
534,205,297
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
AZN
AZN
-0.110
(-0.16%)
70.410 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
JNJ
JNJ
0.360
(0.24%)
152.930 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
NVS
NVS
0.240
(0.21%)
112.750 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
SNY
SNY
-0.515
(-0.98%)
51.995 USD
المزيد
الأخبار المقالات

العنوان: Eton Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.